Introduction: cytomegalovirus (CMV) infection has been reported to be associated with onset/exacerbation of systemic lupus erythematosus (SLE). In an attempt to verify this, we studied CMV infection in SLE patients.
Methods: forty-two SLE patients were studied at 3-time points; disease onset/flare, at peak of immunosuppression (at 6 weeks) and at low doses of immunosuppression (at 6 months). We studied healthy blood donors as controls, only once. Clinical assessment and SLE Disease Activity Index scoring were done at each visit. RT-PCR and ELISA were performed to detect CMV viral-load and anti-CMV antibodies (Ab) respectively.
Results: nine of 106 patients had detectable viral-load (145-50,000 copies/ml). Of these nine, three patients had significant viral-load, 6 patients had low viral-loads of doubtful clinical significance. None of the patients developed CMV disease. Six of 42 cases were positive for IgM Abs. All controls were negative for CMV DNA as well as CMV IgM Abs. All samples from patients and controls were positive for CMV IgG Ab indicating widespread prevalence.
Conclusion: significantly, a higher seroprevalence of CMV IgM Abs against CMV observed in SLE patients when compared to controls, indicating possible reactivation due to immune modulation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648478 | PMC |
| http://dx.doi.org/10.11604/pamj.2020.37.38.18836 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cross-reactivity between dengue virus and SARS-CoV-2 antibodies: Confirmation study using specimens from dengue-infected patients before the COVID-19 pandemic.
Heliyon
November 2024
Institute of Tropical Disease, Universitas Airlangga, Surabaya, 60115, East Java, Indonesia.
Article Synopsis
- * The research tested 238 pre-COVID-19 confirmed dengue serum samples for SARS-CoV-2 antibodies, using rapid tests and ELISA to compare results with dengue samples from the pandemic and COVID-19 patients.
- * Findings indicated only a small percentage (6.7%) of dengue-positive samples reacted to SARS-CoV-2, suggesting low cross-reactivity; however, caution is advised in interpreting serological test results due to the potential for false positives.
Efficient Plasma Cell Differentiation by B Cell Receptor Activation and Cytokine Stimulation.
Immune Netw
October 2024
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
Article Synopsis
- Plasma cells (PCs) are a small subset of B cells which makes them hard to study biochemically, highlighting the need for effective generation methods.
- The study introduces a new culture system for PC differentiation that starts with B cell receptor (BCR) stimulation, addressing limitations of current methods that rely on T cell-independent signals.
- By combining anti-IgM, anti-CD40 Abs, and specific cytokines like IL-4 and IL-5, the researchers achieved efficient PC differentiation, producing abundant PCs that express key markers and secrete high levels of antibodies, paving the way for deeper studies on PC biology.
Serum anti-NMDA receptor antibodies are linked to memory impairment 12 months after stroke.
Mol Psychiatry
October 2024
Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.
Article Synopsis
- Patients who have suffered a stroke are at higher risk for developing post-stroke dementia, and the presence of serum anti-NMDA receptor autoantibodies (NMDAR1-abs) may negatively impact cognitive outcomes, particularly memory.
- In a study using the DEMDAS cohort, researchers found that 10.2% of stroke patients were seropositive for NMDAR1-abs, but this did not correlate with overall cognitive decline.
- However, those with NMDAR1-abs did show significantly worse performance in memory tasks and were more likely to experience memory impairment one year post-stroke, indicating a specific link between these autoantibodies and memory dysfunction.
Challenges in the Development of NK-92 Cells as an Effective Universal Off-the-Shelf Cellular Therapeutic.
J Immunol
November 2024
Henan Province Engineering Research Center of Innovation for Synthetic Biology, School of Life Sciences and Technology, Xinxiang Medical University, Xinxiang, Henan, China.
The human-derived NK-92 cell-based CAR-NK therapy exhibits inconsistency with overall suboptimal efficacy and rapid in vivo clearance of CAR-NK92 cells in cancer patients. Analysis indicates that although pre-existing IgM in healthy individuals (n = 10) strongly recognizes both NK-92 and CAR-NK92 cells, IgG and IgE do not. However, only a subset of cancer patients (3/8) exhibit strong IgM recognition of these cells, with some (2/8) showing pre-existing IgG recognition.
View Article and Find Full Text PDFEstimates of Sequences with Ultralong and Short CDR3s in the Bovine IgM B Cell Receptor Repertoire Using the Long-read Oxford Nanopore MinION Platform.
Immunohorizons
September 2024
Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Cattle produce Abs with an H chain ultralong CDR3 (40-70 aa). These Abs have been shown to have features such as broad neutralization of viruses and are investigated as human therapeutics. A common issue in sequencing the bovine BCR repertoire is the sequence length required to capture variable (V) and isotype gene information.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!